期刊文献+

聚维酮K30、S630对尼美舒利分散片分散性能的影响 被引量:1

Comparison of Dispersibility Between Plasdone K30 and Plasdone S630 in Nimesulide Dispersible Tablets
原文传递
导出
摘要 目的:比较2种聚维酮类亲水性黏合剂对尼美舒利分散片分散性能的影响。方法:分别选择聚维酮S630和K30的5%乙醇溶液及5%水溶液作为亲水性黏合剂制备尼美舒利分散片,通过检测各组分散片的脆碎度、硬度和分散性比较二者对分散片性能的影响。结果:从分散片的脆碎度、硬度和分散性等方面考察,聚维酮S630的乙醇溶液或水溶液与K30的乙醇溶液或水溶液比较性能相同甚至在分散性方面前者更好。结论:聚维酮S630可以作为K30的替代物用作分散片的亲水性黏合剂。 OBJECTIVE: To compare dispersibility between two kinds of plasdone used as the hydrophilic adhesive in nimesulide dispersible tablets. METHODS: Nimesulide dispersible tablets were prepared with Plasdone S630 and Plasdone K30 as the hydrophilic adhesive respectively which were dissolved in 5% alcohol solution or 5% water solution. By friability, hardness and dispersibility tests, the influence of S630 and K30 in quality of nimesulide dispersible tablets were observed. RESULTS: Plasdone S630 alcohol solution or aqueous solution showed same or better results in friability, hardness and dispersibility compared with Plasdone K30 alcohol solution or aqueous solution. CONCLUSION: Plasdone S630 could be used as a alternate of K30 for hydrophilic adhesive in dispersible tablets.
出处 《中国药房》 CAS CSCD 北大核心 2009年第19期1486-1487,共2页 China Pharmacy
关键词 聚维酮K30 聚维酮S630 尼美舒利分散片 黏合剂 Plasdone K30 Plasdone $630 Nimesulide dispersible tablets Adhesive
  • 相关文献

参考文献2

二级参考文献4

共引文献6

同被引文献33

  • 1Moroni A. A novel copovidone binder for dry granulation anddirect compression tabletting [J]. Pharm Tech, 2001, 24(9):8-12.
  • 2Kolter K, Flick D. Structure and dry binding activity ofdifferent polymers, including Kollidon VA 64 [J]. Drug DevInd Pharm, 2000, 26(11): 1159-1165.
  • 3Maniruzzaman M, Rana MM, Boateng JS, et al. Dissolutionenhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers [J]. Drug Dev IndPharm, 2013, 39(2): 218-227.
  • 4Mahmah 0, Tabbakh R, Kelly A,et al. A comparative studyof the effect of spray drying and hot-melt extrusion onthe properties of amorphous solid dispersions containingfelodipine [J]. J Pharm Pharmacol’ 2014, 66 (2): 275-284.
  • 5Leuner C, Dressman J. Improving drug solubility for oraldelivery using solid dispersions [J]. Eur J Pharm Biopharm,2000,50(1):47-60.
  • 6Vasconcelos T,Sarmento B, Costa P. Solid dispersions asstrategy to improve oral bioavailability of poor water solubledrugs [J]. Drug Discov Today, 2007,12 (23-24): 1068-1075.
  • 7Matsumoto T, Zografi G. Physical properties ofsolid molecular dispersions of indomethacin withpoly (vinylpyrrolidone) and poly (vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization [J].Pharm Res, 1999,16(11): 1722-1728.
  • 8Rowe RC,Sheskey PJ, Quinn ME. Handbook ofpharmaceutical excipients [M] . 6th ed, London:Pharmaceutical Press and American Pharmacists Association,2009: 197.
  • 9He H, Yang R, Tang X. In vitro and in vivo evaluation offenoflbrate solid dispersion prepared by hot-melt extrusion[J]. Drug Dev Ind Pharm, 2010,36(6): 681-687.
  • 10Ghebremeskel AN, Vemavarapu C, Lodaya M. Use ofsurfactants as plasticizers in preparing solid dispersionsof poorly soluble API: stability testing of selected soliddispersions [J]. Pharm Res, 2006,23 (8): 1928-1936.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部